Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment
Clinical trial NCT02389452 · COMPLETED
Trial details
- NCT number
- NCT02389452
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-09-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.